Immune thrombocytopenia (ITP) in pregnant women can cause neonatal thrombocytopenia by transport of anti platelet autoantibodies across the placenta.
Introduction
Immune thrombocytopenia (ITP) is present in 4.1% of thrombocytopenic pregnant women. 1 In ITP patients, immunoglobulin G (IgG) autoantibodies can be formed, targeting platelet α IIbβ 3 or glycoprotein IbIX. Maternal IgG can be actively transported across the placenta resulting in neonatal thrombocytopenia. Following
For personal use only. on August 16, 2017. by guest www.bloodjournal.org From decline in neonatal platelet count during 7 days after delivery, the count gradually increases corresponding to the half-life of the passively transported maternal antiplatelet IgG. Usually, normalization of the infant's platelet count occurs within two months. 2 We recently observed a neonate of a mother with ITP whose platelet count was persistently low for 4 months and recovered upon discontinuation of breastfeeding.
The objective of our study was to discern the mechanism responsible for the persistently low platelet count in breastfed newborns and examine additional thrombocytopenic neonates whose mothers had ITP during pregnancy. Another group of patients were women who had a history of ITP yet had normal platelet counts during the current pregnancy and no neonatal ITP.
Methods:
The index patient AH (age 36) had severe ITP during pregnancy and was treated by corticosteroids and intravenous γ -globulin infusions (IVIG). At term, her platelet count was 16,000/µl and her newborn's count 42,000/µl. The infant's counts reached a nadir of 25,000/µl at one month. At 3 months, breastfeeding was discontinued and within one month the platelet count recovered. A milk sample was taken one month after delivery.
Groups of patients
Milk samples were obtained from 6 additional ITP patients whose neonates had thrombocytopenia ( Table 1) . Maternal ITP was diagnosed by exclusion of other causes of thrombocytopenia, presence of purpura and no antiphospholipid antibodies.
Six other patients (designated R-ITP) had a history of ITP but recovered before their current pregnancy. Normal platelet counts were observed in these women and their neonates. Milk was also obtained from 9 healthy women. The study was approved by the Institutional Review Boards of Laniado and Tel-Aviv Medical Centers an conducted in accordance with the Declaration of Helsinki. 
Results and Discussion
The representative case AH had ITP diagnosed during pregnancy and her infant had thrombocytopenia that persisted 4 months. We examined AH's milk sample for anti-platelet antibodies by using an antibody that recognizes the IgG, IgA, and IgM. Figure 1A demonstrates a
For personal use only. on August 16, 2017. by guest www.bloodjournal.org From high level of anti-platelet antibodies in the milk-Ig sample of AH compared to milk-Ig of control. Next, we tested whether the antibodies were of IgG, as in sera of most cases of chronic ITP, or IgA, the predominant type in breast milk. The milk sample of AH contained anti-platelet antibodies which were solely IgA ( Fig 1B and C) . To identify the specific antigen against which the antibodies reacted, we tested the Ig samples also with cultured cells expressing integrin α IIbβ 3 and compared the results to mock cells. Fig 1D shows that anti-αIIbβ 3 antibodies were abundant in AH's milk-Ig sample. resulting in a significant difference between the ITP group to controls (p<0.01).
Presence of anti platelet antibodies in the milk of the three groups of patients
Our study provides the first evidence for presence of anti-platelet antibodies in breast milk of ITP patients associated with neonatal persistent thrombocytopenia. These
For personal use only. on August 16, 2017. by guest www.bloodjournal.org From antibodies were of the IgA type and were recognized by epitopes on α IIbβ 3 . IgA antibodies can be absorbed along the infant's gastrointestinal tract and gain access to the circulation. 5 Anti-αIIbβ 3 antibody was also found in one control sample which might be explained by the broad spectrum of IgA antibodies found in colostrum samples of healthy mothers and were suggested to be important for the anti-idiotype network. 6 The primary mechanism for platelet destruction in ITP is thought to be autoantibodydependent phagocytosis, especially in cases of anti-αIIbβ 3 antibodies 2,7 . IgA which interacts with FcαRI expressed on monocytes and macrophages can initiate antibodydependent cell-mediated cytotoxicity. On the other hand, infants' immune system is immature during the first months. Therefore, the mechanism for the breastfed-neonate thrombocytopenia is an issue for further investigation.
The hypothesis that milk from ITP women can cause thrombocytopenia in the infant was discussed in a series of articles and letters. Kelemen et al 8 suggested that the colostrum of ITP patients contributed to the lowering of circulating platelet counts in the first postnatal days. This was supported by high levels of Ig found in colostrumfed infants on the 5 th postpartum day compared to formula-fed. 9 Hence, lactation was discouraged. 10 In contrast, Meschengieser and Lazzari 11 described an ITP patient who gave birth to a thrombocytopenic preterm infant who was breastfed from day 5 without apparent adverse effects on his platelet count. Bussel in his review 12 mentioned a case of persistent thrombocytopenia who recovered only when breastfeeding was avoided. In our view, breastfeeding should not be discouraged but when low platelet counts persist, discontinuing breastfeeding is a viable solution. Table 1 . Clinical and laboratory features of two groups of lactating patients: ITP group -7 mothers who had ITP during pregnancy and their neonates were born with thrombocytopenia , R-ITP group -6 mothers who had recovered from ITP and in the current pregnancy had normal platelet count and also their neonates. 
Frequency of positive
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